Monoclonal antibodies (mAbs) lecanemab and donanemab have been approved for the treatment of early Alzheimer’s disease in the UK and USA respectively while lecanemab...
The United Kingdom and the European Commission (EC) have reached an agreement on the UK's participation in Horizon Europe (EU's research and innovation) programme...